Everolimus 70377-0092-23

Package NDC

70377-0092-23

Manufacturer: Biocon Pharma Inc.
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: January 14, 2026
Listing Expires: December 31, 2027
Application: ANDA217216

Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Everolimus	5 mg/1

Drug Class

Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]

Selected Package

70377-0092-23Selected

4 BLISTER PACK in 1 CARTON (70377-092-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK

Other packages for this product(1)

70377-0092-11

28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11)

View →